US45841N1072 - Common Stock

**IBKR** gets a fundamental rating of **4** out of 10. The analysis compared the fundamentals against 220 industry peers in the **Capital Markets** industry. While **IBKR** is still in line with the averages on profitability rating, there are concerns on its financial health. **IBKR** is not valued too expensively and it also shows a decent growth rate.

In the past year **IBKR** was profitable.

In the past year **IBKR** had a positive cash flow from operations.

Each year in the past 5 years **IBKR** has been profitable.

With an excellent **Return On Invested Capital** value of **8.96%**, **IBKR** belongs to the best of the industry, outperforming **81.11%** of the companies in the same industry.

The **Average Return On Invested Capital** over the past 3 years for **IBKR** is significantly below the industry average of **17.69%**.

The last **Return On Invested Capital** (**8.96%**) for **IBKR** is above the 3 year average (**7.81%**), which is a sign of increasing profitability.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.5% | ||

ROE | 17.34% | ||

ROIC | 8.96% |

ROA(3y)0.36%

ROA(5y)0.3%

ROE(3y)14.31%

ROE(5y)12.81%

ROIC(3y)7.81%

ROIC(5y)6.92%

In the last couple of years the **Profit Margin** of **IBKR** has remained more or less at the same level.

With a **Gross Margin** value of **49.80%**, **IBKR** perfoms like the industry average, outperforming **47.47%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 39.37% | ||

PM (TTM) | 7.88% | ||

GM | 49.8% |

OM growth 3Y-7.99%

OM growth 5Y-4.64%

PM growth 3Y-0.64%

PM growth 5Y1.35%

GM growth 3Y-13.16%

GM growth 5Y-5.85%

The number of shares outstanding for **IBKR** has been increased compared to 1 year ago.

The number of shares outstanding for **IBKR** has been increased compared to 5 years ago.

The debt/assets ratio for **IBKR** is higher compared to a year ago.

Based on the Altman-Z score of **0.22**, we must say that **IBKR** is in the distress zone and has some risk of bankruptcy.

Looking at the **Debt to FCF ratio**, with a value of **2.37**, **IBKR** is in the better half of the industry, outperforming **78.34%** of the companies in the same industry.

A Debt/Equity ratio of **4.00** is on the high side and indicates that **IBKR** has dependencies on debt financing.

Even though the debt/equity ratio score it not favorable for **IBKR**, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 4 | ||

Debt/FCF | 2.37 | ||

Altman-Z | 0.22 |

ROIC/WACCN/A

WACCN/A

A Quick Ratio of **0.99** indicates that **IBKR** may have some problems paying its short term obligations.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.99 | ||

Quick Ratio | 0.99 |

Measured over the past years, **IBKR** shows a very strong growth in **Earnings Per Share**. The EPS has been growing by **22.04%** on average per year.

Looking at the last year, **IBKR** shows a very strong growth in **Revenue**. The Revenue has grown by **38.50%**.

EPS 1Y (TTM)28.12%

EPS 3Y33.92%

EPS 5Y22.04%

EPS Q2Q%33.33%

Revenue 1Y (TTM)38.5%

Revenue growth 3Y46.38%

Revenue growth 5Y27.13%

Sales Q2Q%21.24%

Based on estimates for the next years, **IBKR** will show a small growth in **Revenue**. The Revenue will grow by **4.21%** on average per year.

EPS Next Y22.45%

EPS Next 2Y10.73%

EPS Next 3Y8.56%

EPS Next 5Y0.01%

Revenue Next Year15.6%

Revenue Next 2Y8.64%

Revenue Next 3Y7.82%

Revenue Next 5Y4.21%

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

The rest of the industry has a similar **Price/Earnings** ratio as **IBKR**.

Based on the **Price/Forward Earnings** ratio of **17.41**, the valuation of **IBKR** can be described as rather expensive.

The rest of the industry has a similar **Price/Forward Earnings** ratio as **IBKR**.

When comparing the **Price/Forward Earnings** ratio of **IBKR** to the average of the S&P500 Index (**21.38**), we can say **IBKR** is valued inline with the index average.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 18.94 | ||

Fwd PE | 17.41 |

Based on the **Enterprise Value to EBITDA** ratio, **IBKR** is valued a bit cheaper than 76.96% of the companies in the same industry.

75.58% of the companies in the same industry are more expensive than **IBKR**, based on the **Price/Free Cash Flow** ratio.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 2.02 | ||

EV/EBITDA | 2.72 |

PEG (NY)0.84

PEG (5Y)0.86

EPS Next 2Y10.73%

EPS Next 3Y8.56%

Compared to an average industry **Dividend Yield** of **8.86**, **IBKR** is paying slightly less dividend.

Compared to an average S&P500 **Dividend Yield** of **2.26**, **IBKR**'s dividend is way lower than the S&P500 average.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 0.79% |

The dividend of **IBKR** has a limited annual growth rate of **0.22%**.

Dividend Growth(5Y)0.22%

Div Incr Years1

Div Non Decr Years11

The dividend of **IBKR** is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.

DP8.66%

EPS Next 2Y10.73%

EPS Next 3Y8.56%

**INTERACTIVE BROKERS GRO-CL A**

NASDAQ:IBKR (9/6/2024, 8:20:23 PM)

After market: 122.54 0 (0%)**122.54**

**-3.52 (-2.79%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap13.34B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 0.79% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 18.94 | ||

Fwd PE | 17.41 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)0.84

PEG (5Y)0.86

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 0.5% | ||

ROE | 17.34% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 39.37% | ||

PM (TTM) | 7.88% | ||

GM | 49.8% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.06

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 4 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 0.99 | ||

Quick Ratio | 0.99 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)28.12%

EPS 3Y33.92%

EPS 5Y

EPS Q2Q%

EPS Next Y22.45%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)38.5%

Revenue growth 3Y46.38%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y